New pill for schizophrenia and Alzheimer's psychosis enters early human testing
Symptom relief
Recruiting now
This early-stage study tests a new extended-release tablet called LY03020 in healthy adults and people with stable schizophrenia. The main goal is to check safety and how the body processes the drug. About 40 participants will receive either the drug or a placebo, and researchers…
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Symptom relief
Last updated May 17, 2026 04:12 UTC